Danaher Corporation (NYSE: DHR) today announced that the Company’s Board of Directors has implemented its previously disclosed succession plan and will appoint Thomas P. Joyce, Jr. as President and Chief Executive Officer and a member of the Board of Directors, effective September 9, 2014. Mr. Joyce’s predecessor, H. Lawrence Culp, Jr., will transition to a senior advisory role. […]
Malvern Instruments Ltd (Malvern, UK) has announced that it has completed the acquisition of MicroCal from GE Healthcare Life Sciences and has also purchased the Archimedes particle characterization system from Affinity Biosensors LLC (Santa Barbara, CA). Both of these developments extend Malvern’s portfolio of analytical solutions for the rapidly advancing biopharmaceutical industry. More…
Oxford Instruments have announced their preliminary results for the year ending March 31st 2014. Jonathan Flint, Chief Executive described it as another successful result highlighted by a growth in orders, sales and profits compared with the previous year. He added that the integration of Andor Technology is progressing well and the business is performing […]
Coherent Inc reports Q1 results for 2014 announcing that net sales have increased by 5.7% over the same period in the previous year, reaching $193.6 million. Net income however, dipped 17.6% compared with the same period last year. for the full release, click here; Coherent, Inc. Reports Q1 Results 2014
Thermo Fisher Scientific reports Q4 and full year 2013 results today, January 30 2014. Highlights include revenue growth of 6% for the quarter to $3.47 billion in 2013, versus $3.26 billion in 2012 and revenue for full year 2013 grew 5% to $13.09 billion, versus $12.51 billion a year ago. Also, the acquisition of Life Technologies to add complementary genomics, next-generation sequencing […]
PerkinElmer announces results for Q4 and full year 2013. Revenues for the full year rose only 2.4% to $2.166 billion but net income rose 135% to $164.8 million from the previous year’s $69.9 million. “We are pleased with our strong finish to the year as we delivered solid performances in adjusted earnings per share growth, […]
Illumina reports a 24% increase in sales to $1.42 billion from the previous year of $1.15 billion. “The fourth quarter capped off a spectacular year for Illumina with robust performance across all products and geographies,” stated Jay Flatley, CEO. “We made significant progress on key R&D programs which allowed us to introduce new products in early 2014 […]
Danaher Corp. has today reported record results both for the final quarter and for the full year. H. Lawrence Culp, Jr., President and Chief Executive Officer, stated, “Our strong finish in 2013 contributed to a solid year for Danaher overall. Our team’s application of the Danaher Business System drove relative top line outperformance, solid […]
CARLSBAD, Calif., Aug. 21, 2013 /PRNewswire/ — Life Technologies Corporation (NASDAQ: LIFE) today announced that its stockholders voted to adopt the previously announced merger agreement providing for the acquisition of Life Technologies by Thermo Fisher Scientific (NYSE: TMO) at the Special Meeting of Stockholders held earlier today. More than 98 percent of votes cast at the Special Meeting […]
Agilent Technologies Inc. (NYSE: A) today reported orders of $1.60 billion, down 4 percent compared with one year ago, and revenues of $1.65 billion for the third fiscal quarter ended July 31, 2013, down 4 percent over one year ago. Third-quarter GAAP net income was $168 million, or $0.49 per share. Last year’s third-quarter […]
For the second quarter ended June 30, 2013, FEI Company (Nasdaq:FEIC) reported bookings that were the highest for any quarter in the company’s history as well as improved gross margins and strong cash flow from operations. Revenue of $222.5 million was a record for a second quarter and was up slightly compared to $221.5 […]
Revenues for the second quarter of 2013 grew by 8.1 percent to $454.9 million, compared to$420.7 million in the second quarter of 2012. Excluding a 0.8 percent negative effect from changes in foreign exchange rates and a 0.6 percent net negative effect from acquisitions and divestitures, Bruker generated organic revenue growth of 9.5 percent in the second quarter […]